Page 16 - 2020Taiwan Food and Drug Administration Annual Report

4FDUJPO cc0WFSWJFX PG %SVHT BOE $POUSPMMFE %SVHT
4FDUJPO c
.BOBHNFOU

I. Medicinal products management framework

In the life cycle management of medicinal products, from product development, preclinical
trials, clinical trials, marketing application, manufacturing to marketing, etc., various good
operating practices must be followed. Different from general consumer goods, medicines can
only be sold on the market after obtaining a marketing authorizations issued by the central
health authority. In order to ensure the safety of the public, TFDA continues to strengthen the
quality management policy throughout the drug life-cycle (Figure 1-5) by the international
harmonization of regulatory management, the establishment of various priority review
mechanisms, digital management, standardization of quality and safety surveillance, inspection
of illegal drugs, management of pharmaceutical vendor and drug circulations, etc. All of these

PHDVXUHV DUH WR HQVXUH WKH VDIHW\ HI¿FDF\ DQG TXDOLW\ RI GUXJV VR WKDW WKRVH LQ QHHG FDQ REWDLQ
them as soon as possible. These measures can also promote the development of biotechnology
industry in Taiwan and create a win-win situation for patients, business owners, and the
government.

"QQMJDBUJPO
1SPEVDU 1SF DMJOJDBM $MJOJDBM GPS
%FWFMPQNFOU 5FTUJOH 5SJBM .BSLFUJOH 1SPEVDUJPO .BSLFUJOH
"QQSPWBM

1SF NBSLFUJOH 3FWJFX 1PTU NBSLFUJOH 4VSWFJMMBODF
(PPE (PPE $MJOJDBM 1SBDUJDF ($1
-BCPSBUPSZ "QQSPWBM 1PTU .BSLFUJOH
1SBDUJDF 5'%" *OTUJUVUJPOBM 3FWJFX #PBSE $IBOHF $POUSPM
(-1 5'%" *3#
1SPEVDUJPO 4PVSDF $POUSPM (PPE .BOVGBDUVSJOH 1SBDUJDF (.1 (PPE 5JTTVF 1SBDUJDF (51
1SPEVDU 3JTL $POUSPM 3JTL &WBMVBUJPO .JUJHBUJPO 4USBUFHJFT
3JTL .BOBHFNFOU 1MBO 3&.4 3.1

(FOFSBM $BTF 4QFDJGJD $POTVMUBUJPO "EWFSTF %SVH %FWJDF 3FBDUJPOT "%3
(PPE 1IBSNBDPWJHJMBODF 1SBDUJDF (1W1

4BGFUZ (PPE %JTUSJCVUJPO 1SBDUJDF (%1
3FHVMBUJPOT (PWFSOJOH UIF 5SBDF BOE
5SBDL 4ZTUFN GPS .FEJDJOBM 1SPEVDUT
(PPE 1IBSNBDZ 1SBDUJDF (11
&GGJDBDZ 2VBMJUZ
1IBSNBDFVUJDBM $BSF
4BGFUZ .FEJDBUJPO &EVDBUJPO
3FWJFX *OTQFDUJPO "OBMZTJT
14
'JHVSF cc-JGF DZDMF NBOBHFNFOU GSBNFXPSL GPS NFEJDJOBM QSPEVDUT